Akari Therapeutics Plc | ||||
NCM : AKTX || Location: United Kingdom | ||||
$1.9+0.04 (+2.15%) |
0.0 M | 1.85 - 1.9 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 0.010 M |
Feb. 29, 2024 | 0.009 M |
Feb. 15, 2024 | 0.009 M |
Jan. 31, 2024 | 0.002 M |
Jan. 12, 2024 | 0.001 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
03/31/2020 | 0.00 | -0.13 | 0.00% |
12/31/2019 | -0.15 | -0.39 | -163.69% |
09/30/2019 | -0.12 | -0.14 | -14.38% |
06/30/2019 | -0.14 | -0.25 | -78.57% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 5.653M | Shares Float | 5.653M |
Short Float | 0.010M | Market Cap | 10.51M |
Institution ownership | 1.94% | Insider ownership | 21.500% |
Earnings Date | 04/29/2024 AMC | Cash Per Share | ? |
Trailing EPS | -2.52 | Forward EPS | -3.40 |